Kyverna Therapeutics: Taking The Next Step In Autoimmune Cell Therapies

I've only had one look at Kyverna Therapeutics ( KYTX ), and at that time a year ago, I had some reservations about their timelines and cash burn, ultimately landing on a "Hold" sentiment at theI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this s ...